GPT Healthcare Valuation
| GPTHEALTH | 178.91 1.86 1.05% |
At this time, the firm appears to be fairly valued. GPT Healthcare retains a regular Real Value of USD176.21 per share. The prevalent price of the firm is USD178.91. Our model calculates the value of GPT Healthcare from analyzing the firm fundamentals such as profit margin of 0.12 %, and Operating Margin of 0.14 % as well as examining its technical indicators and probability of bankruptcy.
Price Book 6.9759 | Enterprise Value 15.4 B | Enterprise Value Ebitda 16.6499 | Price Sales 3.819 | Trailing PE 32.1876 |
Fairly Valued
Today
Please note that GPT Healthcare's price fluctuation is very steady at this time. Calculation of the real value of GPT Healthcare is based on 3 months time horizon. Increasing GPT Healthcare's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the GPT stock is determined by what a typical buyer is willing to pay for full or partial control of GPT Healthcare. Since GPT Healthcare is currently traded on the exchange, buyers and sellers on that exchange determine the market value of GPT Stock. However, GPT Healthcare's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 178.91 | Real 176.21 | Hype 178.91 | Naive 182.1 |
The intrinsic value of GPT Healthcare's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence GPT Healthcare's stock price.
Estimating the potential upside or downside of GPT Healthcare helps investors to forecast how GPT stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of GPT Healthcare more accurately as focusing exclusively on GPT Healthcare's fundamentals will not take into account other important factors: GPT Healthcare Cash |
|
GPT Healthcare Total Value Analysis
GPT Healthcare is currently expected to have takeover price of 15.36 B with market capitalization of 15.35 B, debt of 305.43 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the GPT Healthcare fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
15.36 B | 15.35 B | 305.43 M |
GPT Healthcare Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of GPT suggests not a very effective usage of assets in December.GPT Healthcare Ownership Allocation
GPT Healthcare has a total of 82.05 Million outstanding shares. GPT Healthcare retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 67.78 (percent) of GPT Healthcare outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.GPT Healthcare Profitability Analysis
The company reported the revenue of 4 B. Net Income was 680.43 M with profit before overhead, payroll, taxes, and interest of 0.About GPT Healthcare Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of GPT Healthcare. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of GPT Healthcare based exclusively on its fundamental and basic technical indicators. By analyzing GPT Healthcare's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of GPT Healthcare's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of GPT Healthcare. We calculate exposure to GPT Healthcare's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of GPT Healthcare's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.7 B | 2.4 B |
GPT Healthcare Quarterly Retained Earnings |
|
Other Information on Investing in GPT Stock
GPT Healthcare financial ratios help investors to determine whether GPT Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GPT with respect to the benefits of owning GPT Healthcare security.